These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Etanercept therapy in children with juvenile rheumatoid arthritis. Hung JJ, Huang JL. J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346 [Abstract] [Full Text] [Related]
3. Treatment with etanercept for patients with juvenile rheumatoid arthritis in Taiwan--a preliminary report. Liang TC, Yang YH, Lin YT, Chiang BL. J Microbiol Immunol Infect; 2005 Dec; 38(6):447-50. PubMed ID: 16341347 [Abstract] [Full Text] [Related]
4. Tumor necrosis factor blockers in rheumatoid arthritis. Pisetsky DS. N Engl J Med; 2000 Mar 16; 342(11):810-1. PubMed ID: 10717018 [No Abstract] [Full Text] [Related]
5. Occurrence of inflammatory bowel disease in four patients with juvenile idiopathic arthritis receiving etanercept or infliximab. Tarkiainen M, Tynjälä P, Vähäsalo P, Lahdenne P. Scand J Rheumatol; 2011 Mar 16; 40(2):150-2. PubMed ID: 20868307 [No Abstract] [Full Text] [Related]
10. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions]. Paul C, Solignac M. Ann Dermatol Venereol; 2010 Apr 24; 137(4 Suppl):13-5. PubMed ID: 20510165 [No Abstract] [Full Text] [Related]
11. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Kekow J, Welte T, Kellner U, Pap T. Arthritis Rheum; 2002 Mar 24; 46(3):843-4. PubMed ID: 11920425 [No Abstract] [Full Text] [Related]
14. New treatments for juvenile idiopathic arthritis. Hashkes PJ, Friedland O, Uziel Y. Isr Med Assoc J; 2002 Jan 24; 4(1):39-43. PubMed ID: 11802310 [No Abstract] [Full Text] [Related]